Home › Funds › Thomasville National Bank › GSK

Thomasville National Bank position in GSK

GSK PLC · Health Care

Thomasville National Bank reported holding 871,467 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$45.7M, representing 2.51% of its reported portfolio and ranking #12 among its reported holdings. Thomasville National Bank has disclosed GSK holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)871.47K sh
Reported value held$45.68M
Portfolio Weight2.51%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Thomasville National Bank's GSK position evolved

Thomasville National Bank first disclosed a stake in GSK in Q3 2023 at 422,046 shares (US$15.3M). The position peaked in Q2 2026 at 871,467 shares, worth US$45.7M. Across 10 filings, Thomasville National Bank increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 871,467 shares valued at US$45.7M — a reduction of -18,631 shares quarter over quarter.. Notable position changes include a 78% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 422.05K $15.30M New
Q4 2023 430.77K $15.96M Add
Q1 2024 453.80K $19.45M Add
Q3 2024 475.38K $19.43M Add
Q4 2024 491.44K $16.62M Add
Q1 2025 877.00K $33.97M Add
Q2 2025 871.65K $33.47M Reduce
Q3 2025 885.84K $38.23M Add
Q4 2025 890.10K $43.65M Hold
Q2 2026 871.47K $45.68M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has Thomasville National Bank held GSK?

Thomasville National Bank has disclosed GSK holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is Thomasville National Bank's current position in GSK?

As of Q2 2026, Thomasville National Bank holds 871.47K shares of GSK (GSK PLC), valued at $45.68M, representing 2.51% of its reported portfolio and ranking #12.

Has Thomasville National Bank been buying or selling GSK?

In the latest 13F filing (Q2 2026), Thomasville National Bank reduced its position in GSK. The position peaked in Q2 2026 at 871.47K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.